Our observations presented above may link high TRIB1 levels mechanistically to the enhanced responses to anthracycline-based chemotherapy, prompting us to characterize how altered Trib1 expression in myeloid cells may alter BC tumor growth. Here, TRIB1 is linked to breast cancer.